HCC cells
The potential value of α-fetoprotein (AFP) classification in clinical practice is demonstrated according to a study published in the Journal of Vascular and Interventional Radiology. The results showed that AFP categories agreed moderately with modified Response Evaluation Criteria In Solid Tumors… Read More
Reviewing Studies
A concentrated dose of anti-CEA CAR-T cells administered precisely at the site of a solid tumor by Pressure-enabled Drug Delivery (PEDD) (TriSalus Life Sciences’) is safe, with encouraging clinical responses, according to the results of a phase 1b clinical trial presented in a poster at the Society… Read More
HCC cells
In patients with ultrasound (US)-invisible early stage hepatocellular carcinoma (HCC), the combined therapy of conventional transarterial chemoembolization (cTACE) followed by fluoroscopy-guided radiofrequency ablation (RFA) was safe and effective resulting in less local tumor progression (LTP) and… Read More
LIver Cancer spot
A nomogram including 6 pre-Y90 radioembolization (RAE) parameters predicted overall survival (OS) post-RAE, according to a study published in Clinical Colorectal Cancer. A total of 103 patients with colorectal cancer liver metastases treated with RAE from September 15, 2009 to March 21, 2017 were… Read More
HCC cells
For the treatment of patients with unresectable hepatocellular carcinoma (HCC), the combination of transcatheter arterial chemoembolization (TACE) with iodine [131I] metuximab infusion may improve local efficacy and overall survival when compared with TACE alone, according to an article in Clinics… Read More
Computed tomography (CT)-guided percutaneous microwave ablation is safe and well-tolerated in patients with renal cell carcinoma (RCC) and achieves nephron preservation similar to existing ablative modalities, according to a study published in the Journal of Vascular and Interventional Radiology.… Read More
HCC liver
A new study found that Y90 radioembolization with glass microspheres given at a boosted dose in patients with large hepatocellular carcinomas (HCCs) may show favorable tumor response. The results, which were published in the Journal of Vascular and Interventional Radiology, also found that the… Read More
Percutaneous image-guided core needle biopsies in tumor >2 cm are safe and effective in obtaining tumour genetic material, according to a study published in the European Journal of Cancer. The study looked at procedural data recorded prospectively between December 2011 and March 2016 for a… Read More
HCC cells
A new study that looked at outcomes of surgical resection after yttrium-90 (Y90) transarterial radioembolization (TARE) in patients with hepatocellular carcinoma found that TARE can serve as a safe bridge to resection. The results were published in the Journal of Vascular and Interventional… Read More
Reviewing Studies
Older age or a higher rate of comorbidities with age do not affect survival in metastatic colorectal cancer when patients receive radiofrequency ablation (RFA), high-dose-rate brachytherapy (HDR-BT), or Y90-radioembolization (Y90-RE), according to a study published in BMC Cancer. An institutional… Read More